Eric Schoen insider trades

Open-market stock purchases and sales by Eric Schoen, Chief Financial Officer at Cassava Sciences Inc, from SEC Form 4 filings since Nov 15, 2011.

Track record: 40% of 5 scored buys are up 5% or more since purchase, averaging -14%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • SAVA Cassava Sciences Inc: 5 buys, 2 sales, last Apr 17, 2025
  • PTIE Pain Therapeutics Inc: other filings, last Oct 31, 2018
  • VRML Vermillion, Inc: 5 buys, last Mar 23, 2017

Get free alerts when Eric Schoen files a new trade →